WCN26-2379 META-ANALYTIC EVALUATION OF SGLT2 INHIBITORS AND RAAS BLOCKADE IN CHRONIC KIDNEY DISEASE: A SYNERGISTIC STRATEGY FOR RENOPROTECTION

Read full text Summarise with VIRAT
Authors: Ahmad Naseer Kaihan, Sulaiman Kaihan, Hashmat Ullah Faizi, Ahmad Baseer Kaihan, Amina Kaihan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sodium-glucose co-transporter 2 (SGLT2) inhibitors and RAAS blockade are now integral to chronic kidney disease (CKD) management. However, the comparative and combined efficacy of these therapies in slowing CKD progression remains incompletely quantified across clinical trials.To evaluate the pooled renal benefits of dapagliflozin, empagliflozin, and RAAS inhibitors individually and in combination, using meta-analytic synthesis of randomized controlled trials (RCTs).

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Diabetes Treatment and Management Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104304–104304
Publication date
25 March 2026
Language
EN